TACC2 Is an Androgen-Responsive Cell Cycle Regulator Promoting Androgen-Mediated and Castration-Resistant Growth of Prostate Cancer

Despite the existence of effective antiandrogen therapy for prostate cancer, the disease often progresses to castration-resistant states. Elucidation of the molecular mechanisms underlying the resistance for androgen deprivation in terms of the androgen receptor (AR)-regulated pathways is a requisit...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Mol Endocrinol
Hlavní autoři: Takayama, Ken-ichi, Horie-Inoue, Kuniko, Suzuki, Takashi, Urano, Tomohiko, Ikeda, Kazuhiro, Fujimura, Tetsuya, Takahashi, Satoru, Homma, Yukio, Ouchi, Yasuyoshi, Inoue, Satoshi
Médium: Artigo
Jazyk:Inglês
Vydáno: Endocrine Society 2012
Témata:
Original Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5417095/
https://ncbi.nlm.nih.gov/pubmed/22456197
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/me.2011-1242
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky